JNK India's public offering garnered robust subscription exceeding 28 times and will get listed on exchanges this week.

Initial public offerings and a secondary offering inspired insider buying at these biotech companies and others.

Historical trends suggest presidential elections don't move the needle, but certain companies have delayed their IPOs because ...

A trio of IPOs are a rare bright spot in Thursday’s market. Major U.S. stock indexes are in the red today, but Rubrik, Loar ...

With Microsoft-backed data security firm Rubrik set to enter the public market this week, talk about the rejuvenated IPO ...

Biotech IPOs surged at the start of 2024, but the rest of the year will depend on Fed rate cuts. Meanwhile, doctors using VR ...

Four companies are scheduled for listing in the coming week with one from the mainboard segment and the rest from the SME ...

Dalal Street is poised to witness the debut of three prominent initial public offerings (IPOs), each offering investors a ...

Cybersecurity software company Rubrik is listing its shares in a long-awaited initial public offering this week, the latest ...

IPOs may make a comeback this year due to an abundance of investment cash, but the risks remain too great for most retail investors.

Rubrik RBRK, is going public at $32 a share, above its $28 to $31 price range. The Palo Alto, Calif.-based company also ...